Which feature best distinguishes proton pump inhibitors (PPIs) from H2-receptor antagonists in terms of their mechanism and clinical efficacy?

Explanation

## Mechanism-Based Distinction Between PPIs and H2 Blockers ### Site and Nature of Action **Key Point:** PPIs and H2 blockers act at fundamentally different points in the acid secretion cascade, which is the primary discriminator between them. | Feature | PPIs | H2 Blockers | |---------|------|------------| | **Target** | H+/K+-ATPase pump (final common pathway) | Histamine H2 receptor on parietal cell | | **Binding** | Irreversible (covalent) | Competitive and reversible | | **Acid inhibition** | 90–95% of 24-hour acid secretion | 60–70% of 24-hour acid secretion | | **Onset** | Delayed (3–5 days for steady state) | Rapid (30–60 minutes) | | **Duration** | Long (effect persists 48–72 hrs after cessation) | Short (6–8 hours; requires multiple daily doses) | ### Why This Matters Clinically **High-Yield:** The irreversible nature of PPI binding means they inhibit acid secretion by blocking the final step — the actual pumping of H+ ions into the gastric lumen. H2 blockers, by contrast, block the *signal* (histamine) that tells parietal cells to activate the pump. This explains why PPIs are more potent and have a longer duration of action. **Clinical Pearl:** Because PPIs irreversibly inhibit the pump, new parietal cells must be synthesized (over 3–5 days) to restore acid secretion. H2 blockers, being reversible, allow immediate recovery of secretion once the drug is cleared. ### Mnemonic **PPI = "Pump Poison" (irreversible)** — once bound, the pump is disabled until new pumps are made. **H2 = "Histamine Hitter" (reversible)** — blocks the signal, not the pump itself. [cite:KD Tripathi 8e Ch 50]